Abstract:Embryonic hematopoietic stem cells (HSC) expand rapidly during development in the fetal liver. Notch1 is required for emergence of the definitive hematopoietic stem cells (HSCs) from the hemogenic endothelium, and is essential for survival and function of HSCs in the fetal liver. The identity of the ligand and the ligand-presenting cell during hematopoietic development is critical to understand how rapid expansion is attained in the fetal liver as well as to identify key niche cells that drive the robust functional potential of embryonic HSCs. In the present study, we have taken a comprehensive approach to determine the ligands and cells that initiate Notch signaling in the fetal liver. To this end, we have performed single-cell analysis for all Notch signaling proteins and many known targets in E14.5 fetal HSCs and adult bone marrow HSCs as well as fetal liver endothelial cells. We determined that Jagged1 (Jag1) is highly expressed in both endothelial cells as well as in fetal HSCs but not in adult HSCs. Our results indicate that loss of hematopoietic Jag1 severely impedes the functional ability of fetal liver HSCs to expand and differentiate during transplantation in an adult host. RNA-Sequencing analysis of fetal HSCs in Jag1-mutant embryos revealed reduced expression of Gata2, Mllt3, and Hoxa7. We determined that fetal liver HSCs, hematopoietic progenitors, myeloid cells and megakaryocytes express high levels of Jag1 protein on their surface. In support for the Jag1 niche function, activation of Notch signaling in Jag1-KO fetal HSCs by immobilized Jag1 ligand rescued gene expression and restored hematopoiesis following transplantation. Our findings indicate that Jag1 expressed on hematopoietic cells is an essential niche factor for maturation of HSCs in the fetal liver and for functional potential of fetal HSCs engrafting in the bone marrow microenvironment. Embryonic hematopoietic stem cells (HSC) expand rapidly during development in the fetal liver. Notch1 is required for emergence of the definitive hematopoietic stem cells (HSCs) from the hemogenic endothelium, and is essential for survival and function of HSCs in the fetal liver. The identity of the ligand and the ligand-presenting cell during hematopoietic development is critical to understand how rapid expansion is attained in the fetal liver as well as to identify key niche cells that drive the robust functional potential of embryonic HSCs. In the present study, we have taken a comprehensive approach to determine the ligands and cells that initiate Notch signaling in the fetal liver. To this end, we have performed single-cell analysis for all Notch signaling proteins and many known targets in E14.5 fetal HSCs and adult bone marrow HSCs as well as fetal liver endothelial cells. We determined that Jagged1 (Jag1) is highly expressed in both endothelial cells as well as in fetal HSCs but not in adult HSCs. Our results indicate that loss of hematopoietic Jag1 severely impedes the functional ability of fetal liver HSCs to expand and differentiate during transplantation in an adult host. RNA-Sequencing analysis of fetal HSCs in Jag1-mutant embryos revealed reduced expression of Gata2, Mllt3, and Hoxa7. We determined that fetal liver HSCs, hematopoietic progenitors, myeloid cells and megakaryocytes express high levels of Jag1 protein on their surface. In support for the Jag1 niche function, activation of Notch signaling in Jag1-KO fetal HSCs by immobilized Jag1 ligand rescued gene expression and restored hematopoiesis following transplantation. Our findings indicate that Jag1 expressed on hematopoietic cells is an essential niche factor for maturation of HSCs in the fetal liver and for functional potential of fetal HSCs engrafting in the bone marrow microenvironment.

Endothelial Jagged-2 Sustains Hematopoietic Stem and Progenitor Reconstitution after Myelosuppression

Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype Through a Soluble Form of Jagged-1

3002 – DAMAGE-RESISTANT MYELOID-DERIVED SUPPRESSOR CELLS DRIVE THE RECOVERY AND REGENERATION OF THE BONE MARROW ENDOTHELIAL HEMATOPOIETIC NICHE BY ACTIVATING NOTCH SIGNALING

Hematopoietic Jagged1 is Required for the Transition of Hematopoietic Stem Cells from the Fetal Liver to the Adult Bone Marrow Niche

A Tie2-Notch1 Signaling Axis Regulates Regeneration of the Endothelial Bone Marrow Niche

Notch Ligand Jagged1 is a Fetal Liver Niche Factor for the Function of Embryonic Hematopoietic Stem Cells

Endothelial Cell-Derived Angiopoietin-Like Protein 2 Supports Hematopoietic Stem Cell Activities in Bone Marrow Niches

Angiopoietin-like Proteins Stimulate HSPC Development Through Interaction with Notch Receptor Signaling.

Adipose-Derived Mesenchymal Stem Cell Facilitate Hematopoietic Stem Cell Proliferation via the Jagged-1/Notch-1/Hes Signaling Pathway

Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate

Notch Signaling Mitigates Chemotherapy Toxicity by Accelerating Hematopoietic Stem Cells Proliferation Via C-Myc.

3158 – FUNCTIONAL POTENTIAL OF FETAL LIVER HEMATOPOIETIC STEM CELLS IS MAINTAINED BY JAGGED1 ACTIVATION OF NOTCH SINGALING

Hematopoietic Jagged1 is a Fetal Liver Niche Factor Required for Functional Maturation and Engraftment of Fetal Hematopoietic Stem Cells.

Genome-wide Epigenetic and Proteomic Analysis Reveals Altered Notch Signaling in EPC Dysfunction

Notch Signaling Is Required for Extramedullary Hematopoiesis in the Adult Liver

Notch-Rbp-J Signaling Regulates The Mobilization And Function Of Endothelial Progenitor Cells By Dynamic Modulation Of Cxcr4 Expression In Mice

Notch Signaling in the Regulation of Hematopoietic Stem Cell

Differential Regulation of Bone Marrow-Derived Endothelial Progenitor Cells and Endothelial Outgrowth Cells by the Notch Signaling Pathway.

Angiocrine Factors from Akt-activated Endothelial Cells Balance Self-Renewal and Differentiation of Haematopoietic Stem Cells

A Domain-Specific Role for NOTCH1 Signaling During Regeneration of the Adult Bone Marrow Endothelial Niche

Targeting JNK Pathway Promotes Human Hematopoietic Stem Cell Expansion